Vanguard Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $63.8K | Sell |
|
|||||
|
2025
Q2 | $819K | Buy |
|
|||||
|
2025
Q1 | $752K | Buy |
|
|||||
|
2024
Q4 | $1.59M | Buy |
|
|||||
|
2024
Q3 | $834K | Hold |
|
|||||
|
2024
Q2 | $874K | Buy |
|
|||||
|
2024
Q1 | $214K | Buy |
|
|||||
|
2023
Q4 | $116K | Buy |
|
|||||
|
2023
Q3 | $181K | Sell |
|
|||||
|
2023
Q2 | $184K | Buy |
|
|||||
|
2023
Q1 | $117K | Sell |
|
|||||
|
2022
Q4 | $248K | Buy |
|
|||||
|
2022
Q3 | $368K | Sell |
|
|||||
|
2022
Q2 | $700K | Buy |
|
|||||
|
2022
Q1 | $962K | Sell |
|
|||||
|
2021
Q4 | $2.29M | Sell |
|
|||||
|
2021
Q3 | $3.39M | Hold |
|
|||||
|
2021
Q2 | $8.55M | Sell |
|
|||||
|
2021
Q1 | $17M | Buy |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|
|||||
|
2020
Q3 | $11.7M | Buy |
|
|||||
|
2020
Q2 | $12.1M | Buy |
|
|||||
|
2020
Q1 | $2.73M | Buy |
|
|||||
|
2019
Q4 | $2.46M | Sell |
|
|||||
|
2019
Q3 | $2.38M | Sell |
|
|||||
|
2019
Q2 | $3.35M | Buy |
|
|||||
|
2019
Q1 | $4.21M | Buy |
|
|||||
|
2018
Q4 | $653K | Sell |
|
|||||
|
2018
Q3 | $4.52M | Buy |
|
|||||
|
2018
Q2 | $2.13M | Buy |
|
|||||
|
2018
Q1 | $7.62M | Buy |
|